PHARMACY

Valeant buys rights to Eisai’s Targretin

BY Alaric DeArment

WOODCLIFF LAKE, N.J. — Valeant Pharmaceuticals has bought rights to a drug used to treat skin cancer from Eisai, the companies said Thursday.

Valeant has bought the rights to Targretin (bexarotene) capsules and gel from Eisai for $65 million upfront, plus additional payments based on certain milestones. Under the deal, Eisai has transferred its regulatory approval application to Valeant, which will assume responsibilities for all regulatory obligations associated with the product in the United States. Eisai will retain rights to the drug outside the United States.

The drug is used to treat skin problems arising from a disease called cutaneous T-cell lymphoma, or CTCL, when at least one systemic therapy has not worked.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves new vial size for Privigen

BY Alaric DeArment

KING OF PRUSSIA, Pa. — The Food and Drug Administration has approved a new vial size for a drug made by CSL Behring to treat a bleeding disorder and an immune disorder, the company said Thursday.

The company announced the approval of a 40 g vial size for Privigen (immune globulin intravenous [human]), used to treat primary immunodeficiency and chronic immune thrombocytopenic purport. The company said the new vial size would simplify preparation and administration of the drug when high volumes are provided. In addition to the new vial size, scheduled for introduction in June, the drug will be available in 5 g, 10 g and 20 g sizes.

"CSL Behring strives to bring new innovations to the healthcare marketplace and deliver products that enhance the patient experience," CSL Behring SVP research and development Val Romberg said. "The 40-gram vial size for Privigen continues that commitment by reducing the complexity of administration and increasing time savings for healthcare providers."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

CVS/pharmacy revamps private-label products

BY Alaric DeArment

WOONSOCKET, R.I. — CVS/pharmacy is making some changes to its Gold Emblem food product line, including enhanced ingredients and new flavors, the retail pharmacy chain said Thursday.

The line has been revamped with more options and a new look. Gold Emblem includes more than 250 products, such as nuts, trail mixes, chips, pretzels, dried candies, cookies, spices, juices, condiments, baking products and breakfast bars. CVS introduced it in 1995, making it one of the first private-label food lines created by a major drug store chain.

"At CVS/pharmacy, we are committed to providing our customers with high-quality store brand product lines at a great value," CVS/pharmacy SVP merchandising Judy Sansone said. "With this in mind, we have reintroduced our Gold Emblem brand with enhanced ingredients, new recipes and an updated design and packaging. As part of our ongoing effort to exceed our customers expectations, we have also incorporated an in-depth taste-testing process for each item within the Gold Emblem line."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?